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Enterovirus D68 Circulating in Iowa 
Enterovirus D68 has been identified through surveillance samples submitted from 
central Iowa. In addition, IDPH is hearing anecdotally that respiratory illnesses are 
occurring across Iowa, as is the case in many Midwestern states.  
 
EV-D68 is one of over 100 different enterovirus serotypes circulating in the U.S. and 
around the world. An estimated 10 to 15 million infections occur in the U.S. each year, 
usually in summer and fall. EV-D68 infections occur less commonly than those with 
other enteroviruses. EV-D68, like other enteroviruses, appears to spread through close 
contact with infected people.  
 
EV-D68 infection often begins with cold-like symptoms include coughing and wheezing. 
Most people will recover at home without complications; however, some people may 
develop severe respiratory illness. Infants, children, and teenagers, especially those 
with a history of asthma, other respiratory issues  or those who have a condition that 
compromises their immune system, are most likely to become severely ill. 
 
There is no vaccine to prevent EV-D68 infections and there is no specific treatment; 
specifically, there are no anti-viral medications currently available for this purpose. Many 
infections will be mild and self-limited, requiring only symptomatic treatment: 
• Drink plenty of fluids. 
• Rest. 
• Stay home so you do not spread the virus to others. 
 
Some people with severe respiratory illness caused by EV-D68 may need to be 
hospitalized and receive intensive supportive therapy. 
 
To help reduce the risk of infection with EV-D68, healthcare professionals should 
recommend the following:  
• Wash hands often with soap and water for 20 seconds, especially after changing 
diapers; 
• Avoid touching eyes, nose, and mouth with unwashed hands; 
• Avoid kissing, hugging, and sharing cups or eating utensils with people who are 
sick; 
• Disinfect frequently touched surfaces, such as toys and doorknobs, especially if 
someone is sick; 
• Stay home when feeling sick, and obtain consultation from your health care 
provider. 
 
Enteroviruses, including EV-D68, are not reportable in Iowa or in the U.S., therefore the 
number of cases of the virus is not tracked. IDPH has not received requests for 
assistance from Iowa healthcare facilities, nor heard that any Iowa healthcare facilities 
are unable to keep up with patient care demands.  
 
Testing Information 
Commercial, multi-pathogen detection systems can detect enteroviruses, and are 
approved by the Food and Drug Administration for use in clinical settings (Luminex 
xTAG RVP, BioFire FilmArray Respiratory Panel, Cepheid Xpert EV); however, these 
systems use broadly reactive primers that amplify RNA from either human rhinoviruses 
(HRVs) or enteroviruses and results are reported as "entero-rhinovirus" or "human 
rhinovirus/enterovirus." Most hospitals are not able to perform enterovirus typing.  
 
CDC will perform typing for healthcare facilities experiencing high numbers of 
unexplained respiratory illnesses.  Testing can be initiated by calling CADE at 800-362-
2736. Upon approval, the State Hygienic Laboratory will coordinate specimen collection, 
test request forms and submission to CDC. 
 
For additional information on recent EV-D68 infections in Illinois and Missouri, visit 
www.cdc.gov/mmwr/pdf/wk/mm63e0908.pdf . 
 
 
